載入...
Immune checkpoint inhibition in the treatment of early stage triple negative breast cancer: 2021 update
There is an emerging body of evidence regarding the use of immunotherapy in early-stage triple negative breast cancer (TNBC), with the recent publication of several phase III and randomised phase II studies examining the role of immune checkpoint inhibitors (ICI) in the neoadjuvant setting in combin...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2022-03-01
|
| 叢編: | Breast |
| 主題: | |
| 在線閱讀: | http://www.sciencedirect.com/science/article/pii/S0960977621010250 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|